Maxia Strategies Introduction
Maxia Strategies was founded in June 2010 to provide high-quality strategic and operational Regulatory support to its biotech and pharma clients. Over the past 10 years, we have supported companies of all sizes from Switzerland, EU, North America and Asia.
Turning scientific and technological life science innovation (Medtech/Diagnostic, Biotech, Foodtech) into successful products and businesses is the core offer of Expertinova AG. Customers are mostly either start-ups or SMEs which need consulting in a specific area, require management on time (rent an executive) or other support. The other group of Expertinova AG customers are investors, banks, funding organizations and similar parties requiring an assessment or a due diligence in the triangle life science + technology + market, or strive to identifying high potential scientific and technical developments, start-up projects or start-up companies.
Headquartered in Lugano, Switzerland, LEX Pharma Consulting aims at providing clients with CMC support worldwide. LEX Pharma specializes in all CMC matters, from drug discovery to post approval changes. Whether it’s support for the definition of GMP starting materials, for the process validation strategy, for a technical transfer or for the preparation of a filing, LEX Pharma will be able to fully support you. They bring extensive experience and professionalism to every case and customize their support to your individual needs.
Widler & Schiemann AG is a consultancy that provides their clients with experienced business professionals to deliver effective and productive business solutions. With affiliates in China, USA, Germany and Switzerland they provide clients with innovative, creative and cost-effective answers to their questions and needs in the areas of Drug Development and Quality Management. Founded in 2012, their 23 Partners and Associate Partners have on average 20 years of experience in the pharmaceutical and biotech industry or regulatory authorities. At Widler & Schiemann AG, they take pride in knowing that they offer the best on-going services for customer’s Drug Development support.
Kristin E.D. Coan cooperates with Maxia Strategies as an expert in scientific and medical writing. She received her Ph.D. in Chemistry and Chemical Biology from the University of California, San Francisco, and performed further postdoctoral research at the Novartis Institutes for BioMedical Research (NIBR) in Basel, Switzerland, before shifting her focus to writing. Kristin has worked with companies of all sizes, delivering a range of scientific communications for pharmaceutical and academic research. She speaks English and French and is a member of the National Association of Science Writers and the European Medical Writers Association.
Extensive experience in writing nonclinical and clinical documents, including (but not limited to) Investigational New Drug applications, New Drug Applications, Briefing Documents, Investigator’s Brochures, protocols, study reports and publications; author of over 50 full papers in peer-reviewed journals; completed 5-year term on the Editorial Board of the Biochemical Journal; completed Professional Development program of European Medical Writers Association. Experience in many disease areas, including oncology, viral diseases, inflammation / auto-immune diseases, immunology, asthma, cardiovascular, gastrointestinal, and metabolic. New chemical entities, biologics and literature-based submissions.